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Introduction to Metamodeling for Reducing
Computational Burden of Advanced Analyses
with Health Economic Models: A Structured
Overview of Metamodeling Methods in a
6-Step Application Process
Koen Degeling , Maarten J. IJzerman, Mariel S. Lavieri, Mark Strong,
and Hendrik Koffijberg
Metamodels can be used to reduce the computational burden associated with computationally demanding analyses
of simulation models, although applications within health economics are still scarce. Besides a lack of awareness of
their potential within health economics, the absence of guidance on the conceivably complex and time-consuming
process of developing and validating metamodels may contribute to their limited uptake. To address these issues, this
article introduces metamodeling to the wider health economic audience and presents a process for applying
metamodeling in this context, including suitable methods and directions for their selection and use. General (i.e.,
non–health economic specific) metamodeling literature, clinical prediction modeling literature, and a previously pub-
lished literature review were exploited to consolidate a process and to identify candidate metamodeling methods.
Methods were considered applicable to health economics if they are able to account for mixed (i.e., continuous and
discrete) input parameters and continuous outcomes. Six steps were identified as relevant for applying metamodeling
methods within health economics: 1) the identification of a suitable metamodeling technique, 2) simulation of data
sets according to a design of experiments, 3) fitting of the metamodel, 4) assessment of metamodel performance, 5)
conducting the required analysis using the metamodel, and 6) verification of the results. Different methods are dis-
cussed to support each step, including their characteristics, directions for use, key references, and relevant R and
Python packages. To address challenges regarding metamodeling methods selection, a first guide was developed
toward using metamodels to reduce the computational burden of analyses of health economic models. This guidance
may increase applications of metamodeling in health economics, enabling increased use of state-of-the-art analyses
(e.g., value of information analysis) with computationally burdensome simulation models.
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Decision analytic models are valuable tools to inform
health policy decisions by estimating the health and eco-
nomic impact of health care technologies. When
decision-analytic models take the form of simulation
models, and particularly if they incorporate patient-level
heterogeneity and stochasticity, the computational power
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of standard desktop computers may be insufficient to
perform computationally demanding analysis within fea-
sible time horizons.1–3 Although it is typically feasible to
perform traditional analyses, such as probabilistic analy-
sis to reflect parameter uncertainty,4 performing more
advanced analyses, such as value of information analy-
sis,5 may not be possible within a feasible time frame
unless simulations are executed in parallel using high-
performance computing clusters. Similarly, if we wish to
optimize some specific model outcome, for example, to
identify a screening or treatment strategy that maximizes
patient outcomes subject to some set of constraints, we
may find that this is infeasible using only desktop com-
puting resources.6
Performing these more advanced analyses may be
computationally challenging, because they can require a
large number of model evaluations (i.e., simulation runs).
For example, suppose a discrete event simulation model
has been developed to estimate the health economic
impact of a novel cancer drug compared with an existing
drug. Now assume that running this simulation model
with 10,000 hypothetical patients for each of the 2 treat-
ment strategies is sufficient to obtain stable outcomes
over model runs and takes approximately 1 min. If an
expected value of perfect parameter information analysis
is to be performed for only 1 group of parameters using
an inner probabilistic analysis simulation loop of 5000
runs and outer simulation loop of 2500 runs, 12.5 million
simulation runs would be required in total. Even if it
only requires 1 min to perform a simulation run, per-
forming this analysis using a brute force approach on a
desktop computer with 8 central processing unit cores
working in parallel would take more than 1000 days.
Metamodeling methods can be applied to reduce the
computational burden of computationally demanding
analyses with simulation models.7,8 A metamodel, also
known as a surrogate model or emulator, in general can
be thought of as a function that approximates an out-
come (i.e., response variable or dependent variable) of a
simulator (i.e., the original simulation model) based on
input that would otherwise have been provided to that
simulator.9 Metamodels are typically defined over the
same (constrained) input parameter range as the corre-
sponding simulator, as caution is needed when extrapo-
lating input parameter values beyond their simulator
range. Since metamodels are computationally cheap to
evaluate, requiring only a fraction of the time that it
takes to evaluate the simulator, they can be used as a sub-
stitute for the simulator to substantially reduce the analy-
sis runtime. In the example above, and as illustrated in
Figure 1, metamodels can be used to replace a health eco-
nomic simulation model. Although this will still require
Figure 1 Illustration of how metamodels can be used in a health economic context to approximate the outcomes of the original
health economic simulation model.
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12.5 million evaluations to be performed, this can be
done in very limited time. For example, if a metamodel
would require approximately 0.1 s to evaluate, perform-
ing the analysis using the metamodel would take 2
instead of more than 1000 days. However, metamodels
themselves take time to build and validate,10,11 but this
will not take 1000 days.
Figure 2, which will be discussed in detail throughout
this article, includes an overview of how metamodels are
developed. After identifying candidate metamodeling
techniques, a set of experiments is to be generated. An
experiment refers to a single sample of values of the
model input parameters (thus, if there are k input para-
meters, a vector of length k), which is different from the
use of the word experiment in the context of clinical stud-
ies. For health economic models, these input parameters
may be probabilities, costs or utilities, for example. Next,
the set of experiments is to be evaluated from the simula-
tor to obtain a training data set that contains the experi-
ments and their corresponding model outcomes, such as
mean or incremental costs and quality-adjusted life-years
(QALYs). Finally, metamodels are fitted to the training
data set to approximate the relationship between simula-
tor inputs and outcomes. Different metamodeling tech-
niques can be used to approximate this relationship, each
of which makes different assumptions about the func-
tional form of the relationship between the inputs and
outcomes of the simulator. Although the extent to which
fitted metamodels can be interpreted varies, this is not of
primary interest when using metamodels to reduce com-
putational burden, because the main aim is to approxi-
mate simulators outcomes accurately and not to make
inferences between inputs and outcomes. Most tech-
niques approximate a single model-outcome, requiring
multiple metamodels to approximate multiple simulator
outputs. Hence, one metamodel can be used to approxi-
mate the net health benefit at a given willingness to pay,
but 2 metamodels would be required to approximate
costs and QALYs separately (Figure 1). After developing
a metamodel, it needs to be validated by assessing its
accuracy in approximating simulator outcomes, which is
done based on a testing data set containing experiments
and outcomes that should be similar but different from
those included in the training data set.
Metamodeling methods are used widely across differ-
ent fields of science and engineering, for example, to
optimize designs of coronary stents,12 high-speed
trains,13 and groundwater remediation,14 as well as to
estimate future water temperatures.15 In health econom-
ics, de Carvalho et al.16 recently demonstrated that a
metamodel can be used to perform probabilistic analysis,
which was not possible in a feasible time frame using
their original model.16 A previous literature review iden-
tified only 13 additional applications of metamodeling
methods in health economics, mostly aiming to perform
value of information analysis and applying various, rela-
tively basic metamodeling methods compared with those
used in other fields of research, suggesting the field of
metamodeling within health economics to be in its
infancy.3 An important reason for the limited uptake of
metamodeling methods within health economics may be
that most health economic models and applied analyses
have, until recently, been relatively simple and could
often be performed within acceptable time frames. Other
potential reasons include a lack of awareness of the
potential of metamodeling methods to reduce runtime
and a lack of guidance on how to apply these methods in
a health economic context, which would explain the
diversity in methods applied.
To increase awareness of the potential for applying
metamodels within health economics, and to provide
guidance for doing so, this study introduces the concepts
of metamodeling to the wider health economic audience
and presents a comprehensive, structured overview of
metamodeling methods deemed suitable for use in a
health economic context. Points of consideration for
selecting and applying metamodeling methods are dis-
cussed, including directions specific to health economics.
Identification of Metamodeling Methods
Metamodeling methods (and the steps to be taken when
applying them) were identified by a scoping literature
search that was performed by K.D. This involved online
searches, searches in Scopus and PubMed, and cross-
referencing. Several publications that provide informa-
tion on steps taken when applying metamodeling meth-
ods in health economics, identified in a recent review,3
were used as a starting point.17-20 Method-specific infor-
mation, other candidate metamodeling methods, and
potentially relevant process steps were identified by itera-
tive searches on methods and process steps introduced in
these publications and by cross-referencing. For exam-
ple, if the impact of different experimental designs on
metamodel performance was discussed in an article
found from a search on a specific metamodeling tech-
nique (i.e., structure of the metamodel), additional
searches on these designs of experiments were performed
to identify further information on these experimental
designs and other designs of experiments. The iterative
search process terminated when additionally found
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Figure 2 Process for developing, validating, and applying metamodeling methods in health economics.
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literature did not result in further inclusion of methods
(i.e., until theoretical saturation was reached).
Metamodeling methods were included only if they are
considered appropriate for use in health economics and
have been commonly used in other fields of research, in
line with the objective of the study. Methods were con-
sidered applicable to health economics if they are able to
account for mixed (i.e., continuous and discrete) input
parameters and continuous outcomes (i.e., response vari-
ables). Typical continuous input parameters of health
economic models are, for example, costs and utilities,
whereas the number of hospital days after a surgical
intervention can be included as a discrete parameter.
Similarly, typical continuous outcomes of interest are the
net health or monetary benefit, total cost, and QALYs.
Relevant steps to be taken when applying metamodeling
methods in health economics were not prespecified but
extracted from the literature as described above and
structured in a process. Metamodeling methods and their
characteristics were described according to this process
and presented in a table or graphs when appropriate. In
addition, examples of packages available to implement
methods in R Statistical Software21 and Python22 were
identified via an online search and introduced along with
the corresponding methods. These 2 software environ-
ments were selected because they can be used to develop
both the health economic simulation model and
metamodel in a single script and are commonly used by
academics, although other software environments such
as SAS, Stata, and C++ can also be used to develop
metamodels.
A Process for Metamodeling in Health
Economics
A 6-step process for metamodeling in health economics
was consolidated, covering methods from selecting suit-
able metamodeling techniques up to validating
metamodel outputs against simulator outputs (Figure 2).
A validated health economic simulation model (i.e.,
simulator) that is considered appropriate to perform the
analysis of interest is a prerequisite, because although
metamodels can theoretically be as accurate as their cor-
responding simulators, they cannot compensate for inac-
curacies or bias in these simulators. Here, the analysis
refers to what is to be analyzed using the original health
economic model but is considered infeasible because of
the associated computational burden. Depending on the
analysis to be performed, the sixth step is facultative, as
will be discussed. As for any type of modeling study, the
process of metamodeling is iterative, since new insights
may question prior decisions. Next, each process step
will be described, including an overview of correspond-
ing methods. An illustration of how this process would
be applied to perform value of information analysis is
presented in Appendix A.
Step 1: Identifying Candidate Metamodeling
Techniques
Identification of theoretically suitable metamodeling
techniques is based on study characteristics, including
the analysis to be performed, type of input parameters
(continuous, discrete, or mixed, i.e., both continuous and
discrete), number of input parameters, and type of out-
come (continuous or discrete). As discussed previously,
the focus here is on techniques capable of handling mixed
input parameters and continuous outcomes. In the pres-
ence of time or budget constraints for metamodel devel-
opment, and when multiple techniques are considered
appropriate for use, modelers can start by selecting and
applying one of these techniques and only select and
apply another technique if the resulting metamodel does
not yield acceptable performance (see step 4).
Tappenden et al18 identified 5 metamodeling tech-
niques for application in value of information analysis:
linear regression, response surface methodology, multi-
variate adaptive regression splines, Gaussian processes,
and neural networks. These techniques are complemen-
ted with symbolic regression, which was also identified
from the review,19 and generalized additive models,
which have been used previously for performing value of
information analysis.23,24 In Table 1, an overview of tech-
niques and their characteristics is provided. For each
metamodeling technique, this overview includes the typi-
cally required number of experiments (which we have
defined as low: n \ 500, or high: n  500), number of
input parameters it allows (which we have defined as
low: n \ 20, or high: n  20), interpretability of the
resulting metamodel structure (which we have classified
as low: not or barely possible to understand relations
between inputs and outputs, moderate: input-output rela-
tions can be understood to some extent, or high: input-
output relations can be understood), and the description
of any R and Python packages available to apply the
technique. Regarding the interpretability of the metamo-
dels’ structures, this is typically not of primary interest
when using metamodeling for reducing computational
burden, as accurate and fast approximation of simulator
outcomes is the main goal.
Simple linear regression is a statistical modeling tech-
nique well known in health economics and, theoretically,
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suitable for metamodeling. This assumes a linear rela-
tionship between independent variables (i.e., input para-
meters) and the dependent variable (i.e., outcome of
interest) and is linear in the regression model para-
meters.55 These models can easily be fitted to data sets of
all sizes, including data sets with large numbers of experi-
ments and input parameters, while allowing for both
continuous and categorical input parameters. Although
fitting linear regression models and interpreting their
structure can be considered relatively easy, they are
unlikely to be useful as metamodels of health economic
simulation models, as the latter typically induce complex
and nonlinear parameter interactions. More advanced
techniques, allowing for more flexible model structures,
are often better suited to represent such simulation models.
Response surface methodology is also linear in the
regression model parameters but does not assume a lin-
ear input-output relationship, and it fits polynomial
regression models to predict responses (i.e., out-
comes).10,27,28 Both continuous and categorical input
parameters can be considered in response surface mod-
els, and data sets including large numbers of experiments
and input parameters can be used. However, high nonli-
nearity will require higher-order polynomials, which will
require larger numbers of experiments; hence, it will
require larger up-front simulator runtime. Although
polynomial models are more difficult to interpret com-
pared with linear models, if desired, general trends of
model parameter influence can still be extracted from
their model structures.
Symbolic regression uses genetic programming to con-
struct a mathematical expression from elementary opera-
tors (e.g., ‘‘+’’ and ‘‘3 ’’) and elementary functions (e.g.,
‘‘log’’), accurately describing the relation between input
parameters and the outcome of interest, without making
any priori assumption about this relationship.32,33 Fitting
an accurate symbolic regression model may take substantial
time, because of a potentially large number of candidate
metamodels (i.e., large solution space). However, symbolic
regression is capable of handling large data sets, including a
large number of mixed input parameters. Symbolic regres-
sion models can be difficult to interpret unless the final
expression is relatively simple or is simplified.
Multivariate adaptive regression splines were devel-
oped to model input-outcome relations that may not be
constant across input space.10,37,38,56 Regression spline
modeling divides the outcome domain into intervals and
then estimates an equation, typically a low-order polyno-
mial, for each interval. Different types of splines can be
distinguished, based on how the number of intervals and
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adaptive regression splines includes an automated input
parameter importance analysis (see step 2). Although
capable of handling large data sets of mixed input para-
meters, regression splines are prone to overfitting. In
contrast to the previously discussed metamodeling tech-
niques, the interpretability of multivariate adaptive regres-
sion splines is limited.
Generalized additive models assume that the depen-
dent variable is a smooth, but unknown, function of the
independent variables.40,43 This unknown underlying
smooth function is usually represented using splines, with
the cubic spline as a common choice. In its simplest case,
a univariate cubic spline represents an arbitrary smooth
single-input function as a series of short cubic polyno-
mials joined piecewise such that the function is twice dif-
ferentiable at the ‘‘knots’’ (i.e., join points). The same
spline can also be represented as the weighted sum of a
series of predetermined ‘‘basis functions’’ that extend
over the whole range of the function input. Simple uni-
variate cubic splines have natural extensions to higher
dimensions and to a metamodeling framework, in which
the spline parameters (i.e., the basis function weights) are
estimated from noisy data. Generalized additive models
can handle large data sets and high numbers of input
parameters, but their structure is difficult to interpret.
Gaussian process regression is a nonparametric regres-
sion method also known as Kriging.10,49 Gaussian pro-
cesses use information on neighbor experiments for new
predictions while directly providing information on the
uncertainty in these predictions. This is unique for
metamodeling techniques, since other techniques require
additional effort to obtain information on prediction
uncertainty. Although Gaussian processes are capable of
considering mixed input parameters,57 Treed Gaussian
processes have been developed specifically for this type of
data.58 The interpretability of Gaussian processes is low.
A disadvantage of Gaussian processes is that computa-
tional burden, both in terms of fitting and predicting,
increases dramatically with increasing numbers of experi-
ments and parameters, limiting their applicability. Hence,
Gaussian processes are often well suited for optimization
problems, which are typically defined by limited numbers
of decision parameters. Furthermore, input parameter
importance analysis can be performed to reduce the num-
ber of parameters (see step 2) and, thereby, computa-
tional burden.
Neural networks are nonparametric models that are
commonly found in machine learning applications. These
models consist of networks of nodes (called neurons) and
layers, which learn about relationships between inputs,
either continuous or categorical, and outputs, typically
using large data sets.10,38,54 Although neural networks
are commonly used for classification, they are also able
to predict continuous outcomes.59 Since no assumption
regarding simulator structure is made, neural networks
may well represent complex (i.e., nonlinear) health eco-
nomic models. Developing large neural networks typi-
cally requires large numbers of experiments, which may
pose challenges regarding obtaining sufficient simulator
samples. Similar to multivariate adaptive regression splines,
generalized additive models, and Gaussian processes, neural
networks are ‘‘black boxes’’ that are hard to interpret.
In conclusion, as illustrated in the selection flowchart
(Figure 3), Gaussian processes are particularly useful
when obtaining sufficient simulator samples to apply the
other techniques is infeasible. Response surface metho-
dology, symbolic regression, multivariate adaptive regres-
sion splines, generalized additive models, and neural
networks are typically useful when sufficient samples can
be obtained from the simulator (i.e., original health eco-
nomic model). If metamodel interpretation is important,
response surface methodology and symbolic regression
can be used to develop metamodels that may be interpre-
table to some extent.
Step 2: Simulating Data Sets
Simulating data from the simulator is crucial in
metamodeling studies, as metamodel performance is
highly dependent on the data used for fitting.9 Modelers
control the number and definition of experiments used
for fitting metamodels, which is fundamentally different
from prediction modeling studies, for which data are
typically observed from clinical studies or registries.55
Furthermore, challenges regarding handling missing data,
reversed causality, omitted variables, and measurement
error are not applicable to metamodeling. There are 5 key
aspects to simulating data sets for metamodeling: 1) the
number of data sets, 2) parameter ranges, 3) design of
experiments, 4) number of experiments, and 5) analysis
used for obtaining simulator outcomes. As explained pre-
viously, an experiment refers to the generation of a single
sample of model input parameter values in a
metamodeling context. Hence, the number of experiments
does not refer to a number of (hypothetical) patients but
to the number of sets of model input parameter values for
which the simulation model is evaluated to create data sets
for metamodel fitting and validation.
As in prediction modeling, 2 distinct data sets are pre-
ferred for metamodeling studies: one for fitting (i.e.,
training or development data set) and one for validation
(i.e., testing or validation data set). In prediction
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modeling studies, validation data sets would typically be
obtained by isolating a proportion of the data from a
single cohort for internal validation or by gathering
additional data from another ‘‘plausibly related’’ cohort
for external validation.55 In metamodeling, however, it is
preferable to obtain 2 separate data sets from the simula-
tor, each having a prespecified design with comprehen-
sive coverage. Obtaining 1 large data set and separating
it in 2 data sets for training and validation may compro-
mise the coverage of these data sets: either data set may
lack the structure and properties induced by the design
of experiments used to generate the single large data set.
By obtaining 2 separate data sets, their structure and
properties according to the design of experiments used
will be maintained, as will be discussed.
The range of values that is to be covered in the data
sets requires careful consideration for each input para-
meter separately. Although metamodels are theoretically
capable of extrapolating beyond the parameter ranges
covered by the data set on which they were fitted, such
extrapolations are not preferable. The ranges that need
to be covered are determined by the ranges of interest in
the analysis that is to be performed using the metamodel.
For example, if a metamodel is developed to optimize a
cancer screening strategy, the ranges that are considered
feasible in the optimization should be the same as those
in the data sets used for fitting and validating the used
metamodel(s). If the screening interval in years is a para-
meter of interest and any value between 1 and 10 is con-
sidered feasible, the parameter range for this parameter
in the training and testing data set should also range
from 1 to 10.
Design of experiments methods determine how sets of
samples of parameter values are selected, which are to be
evaluated from the simulator in order to obtain data sets
for fitting and validation.60 The objective of these meth-
ods is to cover parameter spaces and parameter interac-
tions as effectively and efficiently as possible (i.e., with
the least number of experiments). Failing to represent
the full parameter spaces and parameter interactions
will decrease metamodel performance. Most common
designs of experiments are so-called single-pass methods
that first define a complete set of experiments, all of
which are subsequently evaluated using the simulator.11
Commonly used designs are random designs, full factor-
ial designs, and Latin hypercube designs.
Random designs, also known as Monte Carlo
sampling methods, obtain n sets of experiments by
Figure 3 Flowchart for the selection of appropriate metamodeling techniques for a specific case study.
Degeling et al. 355
generating n draws from the joint probability distribu-
tion for the input parameters.60 These designs require a
large number of experiments to sufficiently cover the
parameter space. Input distributions may be designed to
cover a prespecified range with equal probability (i.e.,
uniform distributions) or may represent judgments about
the true unknown value of some population quantity,
for example, using Gamma distributions for parameters
with a positive range.4 When a random design is used, 1
large data set can be separated in 2 data sets for fitting
and validation, while maintaining its random properties.
Full factorial designs fully enumerate possible combi-
nations of discrete parameter values.11 More specifically,
for n values of k parameters, a full factorial design repre-
sents all nk combinations of these parameter values.
Although full factorial designs are able to cover the full
parameter space and interactions, the number of experi-
ments increases exponentially with the number of para-
meters, and they are, therefore, often infeasible to use.
Fractional factorial designs have been introduced to
address challenges regarding high numbers of experi-
ments when using factorial designs and consist of subsets
of full factorial designs.61
Latin hypercube designs have been used often for
designing computer experiments, as they efficiently cover
the full parameter space.60,62,63 In its simplest form,
Latin hypercube samples represent random combina-
tions of values for each parameter, which are equally
spaced between their minimum and maximum value for
each parameter. More often, Latin hypercube samples
represent random combinations of random values from
equally sized bins that cover the parameters’ domains.
Over the years, more advanced versions have been devel-
oped, such as the maximin Latin hypercube design,64
which maximizes the minimum distance between design
points, and orthogonal Latin hypercube designs.65
Figure 4 illustrates how random, full factorial, and
maximin Latin hypercube designs may define 9 experi-
ments for 2 continuous parameters TestCost and
ConsultationCost. Although simulators and metamodels
in practice will have more than 2 parameters, this figure
clearly demonstrates differences between the designs. It
shows that parameter spaces are most effectively covered
by maximin Latin hypercube sampling, as the corre-
sponding experiments are properly distributed over all
bins of the parameter ranges. Conversely, the full factor-
ial design covers some bins multiple times and others not
at all. The randomly sampled experiments also cover
some bins multiple times and others not at all, although
which bins those are is determined by chance. From this
figure, it can also be seen why simply isolating a
proportion of experiments from the data set for model
validation is not appropriate, and a separate data set
needs to be simulated when a nonrandom design is used.
Isolating a (random) proportion from a data set gener-
ated according to a full factorial or Latin hypercube
design will result in a training data set that no longer
covers the full parameter space consistently. The remain-
ing experiments will no longer cover all bins of the para-
meter domain in a Latin hypercube design or all
parameter value combinations in a full factorial design.
In general, Latin hypercube designs are preferable for
both training and testing data sets, especially when only
a limited number of experiments can be evaluated from
the simulator in the available time. Optimized Latin
hypercube designs can easily be generated in most soft-
ware environments, for example, using the lhs package
in R66 or the pyDOE package in Python. However, these
designs are challenging to apply when constraints on
combinations of parameters are applicable. Although
some work has been done on conditioned Latin hyper-
cube designs, accounting for inequality constraints,67 this
might not enable all constraints to be accounted for. In
such situations, factorial designs can be used if the result-
ing number of experiments is considered feasible.
However, when using factorial designs for continuous
variables, a finite set of discrete values within the contin-
uous parameter range needs to be defined, which may
result in an infeasible number of experiments to cover
those parameters’ ranges at the desired level of detail. If
using a factorial design is considered infeasible, random
designs allow constraints to be accounted for easily.
However, random designs are likely less efficient, which
may result in suboptimal solution space coverage and,
consequently, lower metamodel performance, especially
when a limited number of experiments can be evaluated
from the simulator.
How many experiments are required (i.e., how large
the n should be) heavily depends on the desired
metamodel accuracy, which will be discussed in step 4.
In addition, the design of experiments method used and
how well the metamodeling techniques match the
unknown relation between inputs and outputs influence
the number of experiments required.68,69 A general rule
of thumb is to start with n= 103 k, where k refers to
the number of input parameters.69,70 After evaluating
model performance for the initial set of experiments (see
step 4), n may be increased until the desired level of over-
all accuracy is achieved (see Appendix A for an exam-
ple). Alternatively, adaptive sampling methods may be
applied to improve accuracy in local regions of the para-
meter space,51 but these methods are outside the scope of
356 Medical Decision Making 40(3)
this study (see the Discussion section). If the desired
model accuracy cannot be achieved with a feasible num-
ber of experiments, importance analysis methods may be
applied to reduce the number of input parameters k, by
analyzing which parameters are most important in terms
of predicting the simulator outcomes.18,72,73 Including
only the most parameters might result in less complex
metamodel structures, and if redundant input parameters
can be removed, metamodel accuracy may improve as
overfitting is reduced.
Whether a deterministic or probabilistic analysis needs
to be performed to evaluate experiments from the
simulator depends on the analysis to be performed with
the metamodel. In a deterministic analysis, the simulator
is evaluated once for the expected values of the input
parameters.4 In a probabilistic analysis, the simulator is
evaluated numerous times, typically thousands of times,
based on parameter values sampled from distributions
that reflect the uncertainty in the parameter values (i.e.,
second-order uncertainty). If a model is nonlinear, which
most health economic models are, health economic out-
comes from a deterministic analysis are not equal to
those of a probabilistic analysis.74 If metamodels are
being used to perform model probabilistic analysis or
Figure 4 Illustration of how a random uniform sample, full factorial design, and maximin Latin hypercube sample may define 9
experiments for 2 continuous parameters, TestCost and ConsultationCost.
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value of information, simulator outcomes based on a
deterministic analysis should be used. If the aim is to per-
form calibration or optimization, simulator outcomes
based on probabilistic analyses are preferred, because
these are the values expected to be observed in reality
given the current information. However, performing a
probabilistic analysis for each experiment might not be
feasible because of the required simulator runtime. In
that case, outcomes from a deterministic analysis may be
used to approximate the outcomes of a probabilistic
analysis, although this should be clearly noted as a lim-
itation when reporting the results.
The stability of outcome estimates is another impor-
tant aspect. If stochastic uncertainty, also referred to as
uncertainty on the patient level or first-order uncer-
tainty, is reflected in a patient-level simulation model,
sufficient hypothetical patients need to be simulated to
obtain stable outcomes. Similarly, regardless of whether
first-order uncertainty is reflected, sufficient probabilistic
analysis runs need to be performed to obtain stable point
estimates. When insufficient hypothetical patients are
simulated, or probabilistic analysis runs performed, the
subsequent noise in the data used for fitting metamodels
may have a pernicious effect on metamodel performance.
Outcomes can be considered stable if the outcomes
obtained from simulations with different random num-
bers, but with the same input parameter values, are suffi-
ciently similar. What defines ‘‘sufficiently similar’’ differs
among case studies and should be discussed with all rele-
vant stakeholders (e.g., care providers, decision makers,
and modelers). Obtaining stable outcomes may require a
substantial number of patients to be simulated or simula-
tion runs to be performed and may not be feasible in
practice. However, to reduce the number of patients to
be simulated or the number of runs to be performed to
obtain stable outcomes, variance reduction techniques
may be applied, such as using common random numbers
when comparing strategies.75,76
Step 3: Fitting Metamodels
After evaluating an initial set of experiments from the
simulator, this training data set can be used to fit selected
metamodeling techniques. Steps involved in the fitting
processes differ between techniques as well as any settings
to be provided. We refer to the corresponding literature
and software documentation to learn about the steps to
be taken and settings to be provided (see step 1 and
Table 1). As a basic example, some metamodeling tech-
niques or software packages require input parameters to
be rescaled. Fitting metamodels is an iterative process, in
which settings may be adapted, or more experiments may
be evaluated from the simulator, after assessing model
performance (see step 4).
Step 4: Assessing Metamodel Performance
Assessing the performance of fitted metamodels is essen-
tial to further improve that performance, by iteratively
improving (extending) the design of the training data set
used or adapting the settings for fitting these models. In
addition, an initially selected metamodeling technique
may be deemed inappropriate if performance does not
reach an acceptable level, resulting in exclusion of this
technique from the list of potential candidates (step 1).
Performance can be assessed using the testing data set
evaluated from the simulator in step 2. Since metamodels
of health economics models will typically predict contin-
uous scale outcomes, of main interest is to quantify how
close predictions are to actual simulator outcomes.
Assessing accuracy and comparing different metamodels
can be done graphically and using quantitative perfor-
mance criteria. A validation plot, with predicted values
on the x-axis and observed values from the simulator on
the y-axis, is fundamental in assessing model perfor-
mance and presents information on systematic trends as
well as general performance (see Appendix A for an
example). Several quantitative performance criteria are
available, including mean or maximum values of the
absolute error, absolute relative error, and squared error,
all of which may be normalized using the sample range
or standard deviation, and summarized by their mean or
maximum values, and R2.38,69,77,78
It is important to be aware of performance criteria
characteristics when selecting one, or several, to compare
metamodels or to assess whether model performance is
acceptable. For example, compared with mean absolute
errors, mean squared errors place more weight on out-
liers. In addition, compared with squared errors, setting
a desired level of accuracy is more straightforward for
absolute (relative) errors, as these can be set by answering
questions such as, ‘‘What is the maximum mean devia-
tion in predicted life-years the metamodel is allowed to
have compared with the simulator outcomes?’’ The per-
formance that can be considered acceptable for deciding
to apply a metamodel for performing analyses differs
among case studies and should be based on input from
all stakeholders. For example, when the point estimate
for the incremental QALYs is 0.18 QALYs, an absolute
error of 0.01 QALY may be considered appropriate by
stakeholders. Since different performance criteria and
definitions of acceptable performance may yield alterna-
tive conclusions, these should be decided upon prior to
metamodel development.
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Step 5: Applying the Metamodel
Once a metamodel has been developed and validated, it
can be used to perform analyses that could not be per-
formed in a feasible time period with the original health
economic model. Previous applications of metamodels in
health economics include value of information analysis,
model calibration, optimization, probabilistic analysis,
and obtaining stable outcomes over multiple runs with
the same input values.3 In addition, metamodels can be
used in online tools for which limited computer resources
are available. For example, see de Carvalho et al.16 for a
demonstration of metamodels used for probabilistic anal-
ysis or Appendix A for an illustration of the presented 6-
step process for performing value of information analy-
sis. Another example may be to use metamodels for eval-
uating a large set of (thousands of) screening strategies,
for example, to identify the starting age, screening inter-
val, and number of screening rounds that optimize health
and economic outcomes.
Step 6: Verifying Results (Optional)
If metamodels are used for optimization purposes, it is
recommended to reevaluate a certain number of best
strategies identified by the metamodel using the original
health economic model, to assess whether their outcome
and ordering meaningfully differ. By providing these
results, decision makers are better informed about the
expected impact of choosing a good but not optimal can-
didate strategy for implementation, which may be
favored over the optimal strategy for practical reasons.
For other types of analyses, such as probabilistic or
value of information analysis, additional verification will
not add to the validation of step 4, because reevaluating
a number of strategies using the simulator will yield
approximately the same error values as those obtained in
step 4. Although this will also be the case for several
best-performing strategies when optimization is per-
formed, knowing the true outcomes and ordering of the
strategies according the simulator is informative, whereas
knowing the true outcome for a specific probabilistic
analysis run is not of any value.
Discussion
This study provides an introduction to metamodeling
methods that can be used to reduce the computational
burden of advanced analyses with health economic mod-
els and addresses challenges regarding the selection and
application of these methods. Similar to ordinary statisti-
cal regression modeling, different methods, which are
discussed, are available with their own advantages, dis-
advantages, and underlying assumptions, and directions
for selecting and implementing these methods are pro-
vided. Selected methods are structured in a comprehen-
sive 6-step process that can be followed to ensure
essential modeling steps are covered, as it includes all rel-
evant design choices. In addition, the process discussed
can be used as a structure to effectively and efficiently
communicate metamodeling studies, to increase model-
ing transparency and reproducibility.
Given that tools and packages are available to gener-
ate experiments according to specific designs and to fit
different types of metamodels, for example, in R and
Python, applying metamodeling methods is feasible for
health economic analysts. Currently available software
and results from this study enable analysts to perform
computationally demanding analyses with their models,
such as value of information analysis, model calibration,
and optimization. The benefits of developing
metamodels are relevant to analyses using patient-level
simulation methods, such as microsimulation state-
transition modeling and discrete event simulation, but
also to cohort models used to perform analyses that
require a large number of model evaluations.
Applying metamodeling methods can reduce compu-
tational burden, but this usually comes at the price of
introducing additional uncertainty in the model outputs.
Consequently, checking whether underlying assumptions
are met and checking metamodel performance are crucial
to success and essential to build confidence in the meta-
model. Since modelers typically have access to the origi-
nal health economic model, validation of the metamodel
is often not a problem, although it is likely to be more
demanding in terms of effort compared with developing
the metamodel itself. The starting point for building any
metamodel, however, should be a realistic and validated
health economic model, since metamodels can theoreti-
cally be as accurate as their corresponding simulators but
will not compensate for inaccuracies in these simulators.
Moreover, when metamodels are used for optimization,
the strategies considered, and possibly identified as opti-
mal, may not be supported by (the data underlying) the
simulator. Caution is required when such extrapolation is
(automatically) performed, and such optimization results
should serve only to initiate discussion on the appropri-
ateness and validity of the simulator and the data sup-
porting it. In addition, the application of metamodeling
methods requires communication of metamodeling
design choices made in publications, for which space is
typically already limited. Hence, metamodeling studies
may be published separately from their simulator to
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ensure the metamodeling process can be appropriately
described. Furthermore, there is a ‘‘sweet spot’’ for meta-
modeling: sufficient experiments need to be evaluated
using the simulator to develop an accurate metamodel,
but evaluating all experiments of interest should not be
feasible.
Several technical challenges remain regarding the
application of metamodeling methods in health econom-
ics. Simulators in health economics may include complex
behavior, such as rigid cutoffs due to clinical decision
rules, which may be complex for metamodeling tech-
niques to capture. In addition, (combinations of) model
input parameters may be subject to constraints, which
are difficult to incorporate in efficient designs of experi-
ments, such as Latin hypercube sampling. If sufficient
samples can be evaluated from the simulator to use ran-
dom or full factorial designs in which constraints can be
accounted for more easily, however, this might not be an
issue. Alternatively, more advanced adaptive sampling
strategies may need to be applied.
Not all metamodeling methods are directly suitable
for application in health economics and hence have not
been discussed. However, it is important to note that
some techniques, such as those that can be used for cate-
gorical outcomes (i.e., classification), could theoretically
be applied in health economics after discretizing continu-
ous outcomes. Such an approach has been taken previ-
ously by using a binary outcome to reflect whether one
treatment was preferred over another in a logistic regres-
sion model.73 Similarly, examples of packages for R and
Python were discussed, whereas additional packages are
likely to be available and other software environments
can also be used to develop metamodels, such as Stata,
SAS, and C++. In addition, alternative performance cri-
teria for metamodel validation can be found, or may be
developed, based on study-specific needs. With regard to
sampling methods, only single-pass methods have been
discussed, whereas iterative methods, also known as
adaptive sampling or active learning methods, also
exist.79,80 Iterative methods use an initial data set for fit-
ting an initial metamodel, which is subsequently used in
an iterative process to identify additional experiments to
be added to the data set, to update the initial metamodel,
and to check the updated metamodel performance, until
this performance is in accordance with a predefined
threshold.71 The additional experiments are sampled in
the area in which performance needs to be improved.
Although iterative methods are more efficient compared
with single-pass methods, they are substantially more
complicated to implement and require simulators to be
available in the same software environment used for
generating experiments and fitting the metamodel.
Nevertheless, these methods may be useful if insufficient
experiments according to a single-pass design can be
obtained to develop an accurate metamodel. Also, alter-
native designs of experiments are available, such as D-
optimal designs, which are efficient and can account for
constraints, but for which an linear or quadratic model
simulator model structure should be known,81 or for so-
called Sobol sequences, which may be more efficient
compared with Latin hypercube designs with low-
dimension (i.e., number of input parameters)
problems.82,83
Future metamodeling applications should further
illustrate the potential and use of these research methods
and also identify common challenges. Once the field of
metamodeling in health economics has evolved, good
research practices (i.e., consensus guidance) can be iden-





Supplementary material for this article is available on the
Medical Decision Making Web site at http://journals.sagepub
.com/home/mdm.
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